294 related articles for article (PubMed ID: 30552295)
1. Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.
Gamage TF; Farquhar CE; McKinnie RJ; Kevin RC; McGregor IS; Trudell ML; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2019 Mar; 368(3):414-422. PubMed ID: 30552295
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA.
Longworth M; Connor M; Banister SD; Kassiou M
ACS Chem Neurosci; 2017 Aug; 8(8):1673-1680. PubMed ID: 28574245
[TBL] [Abstract][Full Text] [Related]
3. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
[TBL] [Abstract][Full Text] [Related]
6. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.
Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR
Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752
[TBL] [Abstract][Full Text] [Related]
7. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
10. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
[TBL] [Abstract][Full Text] [Related]
11. Defining Steric Requirements at CB
Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB
Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD
Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091
[TBL] [Abstract][Full Text] [Related]
17. In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs.
Deventer MH; Persson M; Norman C; Liu H; Connolly MJ; Daéid NN; McKenzie C; Gréen H; Stove CP
Drug Test Anal; 2024 Jun; 16(6):616-628. PubMed ID: 37903509
[TBL] [Abstract][Full Text] [Related]
18. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
20. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
Noble C; Cannaert A; Linnet K; Stove CP
Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
